Mediwound Stock Shares Outstanding
| MDWD Stock | USD 18.95 0.05 0.26% |
Mediwound fundamentals help investors to digest information that contributes to Mediwound's financial success or failures. It also enables traders to predict the movement of Mediwound Stock. The fundamental analysis module provides a way to measure Mediwound's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Mediwound stock.
The current year's Common Stock Shares Outstanding is expected to grow to about 9.5 M. Mediwound | Shares Outstanding |
Mediwound Company Shares Outstanding Analysis
Mediwound's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Mediwound Shares Outstanding | 9.49 M |
Most of Mediwound's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mediwound is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Mediwound Shares Outstanding Driver Correlations
Understanding the fundamental principles of building solid financial models for Mediwound is extremely important. It helps to project a fair market value of Mediwound Stock properly, considering its historical fundamentals such as Shares Outstanding. Since Mediwound's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Mediwound's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Mediwound's interrelated accounts and indicators.
Click cells to compare fundamentals
Mediwound Shares Outstanding Historical Pattern
Today, most investors in Mediwound Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Mediwound's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Mediwound shares outstanding as a starting point in their analysis.
Mediwound Shares Outstanding |
| Timeline |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Mediwound Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, Mediwound has 9.49 M of shares currently outstending. This is 94.74% lower than that of the Pharmaceuticals sector and 91.12% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 98.34% higher than that of the company.
Mediwound Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mediwound's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Mediwound could also be used in its relative valuation, which is a method of valuing Mediwound by comparing valuation metrics of similar companies.Mediwound is currently under evaluation in shares outstanding category among related companies.
Mediwound Fundamentals
| Return On Equity | -0.32 | ||||
| Return On Asset | -0.17 | ||||
| Profit Margin | (0.36) % | ||||
| Operating Margin | (0.77) % | ||||
| Current Valuation | 139.89 M | ||||
| Shares Outstanding | 9.49 M | ||||
| Shares Owned By Insiders | 25.72 % | ||||
| Shares Owned By Institutions | 34.51 % | ||||
| Number Of Shares Shorted | 171.63 K | ||||
| Price To Earning | 16.58 X | ||||
| Price To Book | 4.80 X | ||||
| Price To Sales | 8.12 X | ||||
| Revenue | 18.69 M | ||||
| Gross Profit | 13.16 M | ||||
| EBITDA | (14.2 M) | ||||
| Net Income | (6.72 M) | ||||
| Cash And Equivalents | 10.41 M | ||||
| Cash Per Share | 0.31 X | ||||
| Total Debt | 6.71 M | ||||
| Debt To Equity | 0.64 % | ||||
| Current Ratio | 1.61 X | ||||
| Book Value Per Share | 3.43 X | ||||
| Cash Flow From Operations | (8.52 M) | ||||
| Short Ratio | 1.85 X | ||||
| Earnings Per Share | (0.75) X | ||||
| Price To Earnings To Growth | (0.07) X | ||||
| Target Price | 28.5 | ||||
| Number Of Employees | 100 | ||||
| Beta | 0.93 | ||||
| Market Capitalization | 179.39 M | ||||
| Total Asset | 66.46 M | ||||
| Retained Earnings | (174.82 M) | ||||
| Working Capital | 38.87 M | ||||
| Current Asset | 50.4 M | ||||
| Current Liabilities | 5.21 M | ||||
| Net Asset | 66.46 M |
About Mediwound Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Mediwound's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mediwound using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mediwound based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Mediwound in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Mediwound's short interest history, or implied volatility extrapolated from Mediwound options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Mediwound Piotroski F Score and Mediwound Altman Z Score analysis. For information on how to trade Mediwound Stock refer to our How to Trade Mediwound Stock guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Complementary Tools for Mediwound Stock analysis
When running Mediwound's price analysis, check to measure Mediwound's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mediwound is operating at the current time. Most of Mediwound's value examination focuses on studying past and present price action to predict the probability of Mediwound's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mediwound's price. Additionally, you may evaluate how the addition of Mediwound to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets |
Is Mediwound's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mediwound. If investors know Mediwound will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mediwound listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.75) | Revenue Per Share 2.073 | Quarterly Revenue Growth (0.54) | Return On Assets (0.17) | Return On Equity (0.32) |
The market value of Mediwound is measured differently than its book value, which is the value of Mediwound that is recorded on the company's balance sheet. Investors also form their own opinion of Mediwound's value that differs from its market value or its book value, called intrinsic value, which is Mediwound's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mediwound's market value can be influenced by many factors that don't directly affect Mediwound's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mediwound's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mediwound is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mediwound's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.